Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis

Non-infectious anterior uveitis (AU) is a potentially sight threatening inflammatory condition. The current gold standard for treatment is topical steroids, but low ocular bioavailability and compliance issues with the intensive dosing regimen limit the efficacy of this treatment. Liposomes as a dru...

Full description

Bibliographic Details
Main Authors: Wong, Chee Wai, Czarny, Bertrand, Metselaar, Josbert M., Ho, Candice, Ng, Si Rui, Barathi, Amutha Veluchamy, Storm, Gert, Wong, Tina T.
Other Authors: School of Materials Science & Engineering
Format: Journal Article
Language:English
Published: 2018
Subjects:
Online Access:https://hdl.handle.net/10356/87423
http://hdl.handle.net/10220/45387
_version_ 1824456095168462848
author Wong, Chee Wai
Czarny, Bertrand
Metselaar, Josbert M.
Ho, Candice
Ng, Si Rui
Barathi, Amutha Veluchamy
Storm, Gert
Wong, Tina T.
author2 School of Materials Science & Engineering
author_facet School of Materials Science & Engineering
Wong, Chee Wai
Czarny, Bertrand
Metselaar, Josbert M.
Ho, Candice
Ng, Si Rui
Barathi, Amutha Veluchamy
Storm, Gert
Wong, Tina T.
author_sort Wong, Chee Wai
collection NTU
description Non-infectious anterior uveitis (AU) is a potentially sight threatening inflammatory condition. The current gold standard for treatment is topical steroids, but low ocular bioavailability and compliance issues with the intensive dosing regimen limit the efficacy of this treatment. Liposomes as a drug delivery system may help to overcome these problems. We studied the efficacy of a PEG-liposomal formulation of liposomal steroids, administered as a single subconjunctival dose, in the treatment of experimental uveitis in rabbit eyes. Rabbits that received subconjunctival liposomal triamcinolone acetonide phosphate (LTAP) or liposomal prednisolone phosphate (LPP) had significantly lower mean inflammatory scores than untreated controls on Day 4 after induction of uveitis (LPP vs controls, p=0.049) and 8 (LPP vs controls, p=0.007; LTAP vs controls, p=0.019), and lower scores than rabbits given topical PredForte1% 4 times a day on Day 8 (p=0.03). After antigen rechallenge, the subconjunctival liposomal steroid groups continued to have greater suppression of inflammation than untreated controls on Day 11 (p=0.02). Localization of liposomes in inflamed ocular tissue was confirmed by histology and immunostaining, and persisted in the eye for at least one month. Our study demonstrates that a single subconjunctival injection of liposomal steroids induces effective and sustained anti-inflammatory action.
first_indexed 2025-02-19T03:48:39Z
format Journal Article
id ntu-10356/87423
institution Nanyang Technological University
language English
last_indexed 2025-02-19T03:48:39Z
publishDate 2018
record_format dspace
spelling ntu-10356/874232023-07-14T15:45:48Z Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis Wong, Chee Wai Czarny, Bertrand Metselaar, Josbert M. Ho, Candice Ng, Si Rui Barathi, Amutha Veluchamy Storm, Gert Wong, Tina T. School of Materials Science & Engineering Lee Kong Chian School of Medicine (LKCMedicine) Anterior Uveitis (AU) Liposomal Steroids Non-infectious anterior uveitis (AU) is a potentially sight threatening inflammatory condition. The current gold standard for treatment is topical steroids, but low ocular bioavailability and compliance issues with the intensive dosing regimen limit the efficacy of this treatment. Liposomes as a drug delivery system may help to overcome these problems. We studied the efficacy of a PEG-liposomal formulation of liposomal steroids, administered as a single subconjunctival dose, in the treatment of experimental uveitis in rabbit eyes. Rabbits that received subconjunctival liposomal triamcinolone acetonide phosphate (LTAP) or liposomal prednisolone phosphate (LPP) had significantly lower mean inflammatory scores than untreated controls on Day 4 after induction of uveitis (LPP vs controls, p=0.049) and 8 (LPP vs controls, p=0.007; LTAP vs controls, p=0.019), and lower scores than rabbits given topical PredForte1% 4 times a day on Day 8 (p=0.03). After antigen rechallenge, the subconjunctival liposomal steroid groups continued to have greater suppression of inflammation than untreated controls on Day 11 (p=0.02). Localization of liposomes in inflamed ocular tissue was confirmed by histology and immunostaining, and persisted in the eye for at least one month. Our study demonstrates that a single subconjunctival injection of liposomal steroids induces effective and sustained anti-inflammatory action. Published version 2018-07-30T07:49:38Z 2019-12-06T16:41:33Z 2018-07-30T07:49:38Z 2019-12-06T16:41:33Z 2018 Journal Article Wong, C. W., Czarny, B., Metselaar, J. M., Ho, C., Ng, S. R., Barathi, A. V., et al. (2018). Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis. Scientific Reports, 8(1), 6604-. 2045-2322 https://hdl.handle.net/10356/87423 http://hdl.handle.net/10220/45387 10.1038/s41598-018-24545-2 en Scientific Reports © 2018 The Author(s) (Nature Publishing Group). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. 11 p. application/pdf
spellingShingle Anterior Uveitis (AU)
Liposomal Steroids
Wong, Chee Wai
Czarny, Bertrand
Metselaar, Josbert M.
Ho, Candice
Ng, Si Rui
Barathi, Amutha Veluchamy
Storm, Gert
Wong, Tina T.
Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
title Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
title_full Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
title_fullStr Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
title_full_unstemmed Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
title_short Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
title_sort evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
topic Anterior Uveitis (AU)
Liposomal Steroids
url https://hdl.handle.net/10356/87423
http://hdl.handle.net/10220/45387
work_keys_str_mv AT wongcheewai evaluationofsubconjunctivalliposomalsteroidsforthetreatmentofexperimentaluveitis
AT czarnybertrand evaluationofsubconjunctivalliposomalsteroidsforthetreatmentofexperimentaluveitis
AT metselaarjosbertm evaluationofsubconjunctivalliposomalsteroidsforthetreatmentofexperimentaluveitis
AT hocandice evaluationofsubconjunctivalliposomalsteroidsforthetreatmentofexperimentaluveitis
AT ngsirui evaluationofsubconjunctivalliposomalsteroidsforthetreatmentofexperimentaluveitis
AT barathiamuthaveluchamy evaluationofsubconjunctivalliposomalsteroidsforthetreatmentofexperimentaluveitis
AT stormgert evaluationofsubconjunctivalliposomalsteroidsforthetreatmentofexperimentaluveitis
AT wongtinat evaluationofsubconjunctivalliposomalsteroidsforthetreatmentofexperimentaluveitis